These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26390062)

  • 1. Exploring the Potential Emotional and Behavioural Impact of Providing Personalised Genomic Risk Information to the Public: A Focus Group Study.
    Smit AK; Keogh LA; Newson AJ; Hersch J; Butow P; Cust AE
    Public Health Genomics; 2015; 18(5):309-17. PubMed ID: 26390062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the emotional and behavioural reactions to receiving personalized melanoma genomic risk information: a qualitative study.
    Fenton GL; Smit AK; Keogh L; Cust AE
    Br J Dermatol; 2019 Jun; 180(6):1390-1396. PubMed ID: 30580464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public preferences for communicating personal genomic risk information: a focus group study.
    Smit AK; Keogh LA; Hersch J; Newson AJ; Butow P; Williams G; Cust AE
    Health Expect; 2016 Dec; 19(6):1203-1214. PubMed ID: 26332492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?
    Smit AK; Keogh LA; Newson AJ; Butow PN; Dunlop K; Morton RL; Kirk J; Espinoza D; Cust AE
    Br J Dermatol; 2017 Sep; 177(3):779-790. PubMed ID: 28627002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.
    Smit AK; Newson AJ; Morton RL; Kimlin M; Keogh L; Law MH; Kirk J; Dobbinson S; Kanetsky PA; Fenton G; Allen M; Butow P; Dunlop K; Trevena L; Lo S; Savard J; Dawkins H; Wordsworth S; Jenkins M; Mann GJ; Cust AE
    Contemp Clin Trials; 2018 Jul; 70():106-116. PubMed ID: 29802966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.
    Aspinwall LG; Stump TK; Taber JM; Drummond DM; Kohlmann W; Champine M; Leachman SA
    Transl Behav Med; 2018 Jan; 8(1):29-43. PubMed ID: 29385581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation considerations for offering personal genomic risk information to the public: a qualitative study.
    Smit AK; Reyes-Marcelino G; Keogh L; Dunlop K; Newson AJ; Cust AE
    BMC Public Health; 2020 Jun; 20(1):1028. PubMed ID: 32600382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.
    Smit AK; Espinoza D; Newson AJ; Morton RL; Fenton G; Freeman L; Dunlop K; Butow PN; Law MH; Kimlin MG; Keogh LA; Dobbinson SJ; Kirk J; Kanetsky PA; Mann GJ; Cust AE
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):212-221. PubMed ID: 27702805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of genetic research and testing among members of families with an increased risk of malignant melanoma.
    Bränström R; Kasparian NA; Affleck P; Tibben A; Chang YM; Azizi E; Baron-Epel O; Bergman W; Chan M; Davies J; Ingvar C; Kanetsky PA; van Leeuwen E; Olsson H; Gruis NA; Brandberg Y; Newton-Bishop J
    Eur J Cancer; 2012 Nov; 48(16):3052-62. PubMed ID: 22726816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan.
    Lo SN; Smit AK; Espinoza D; Cust AE;
    Trials; 2020 Jun; 21(1):594. PubMed ID: 32605576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma.
    Smit AK; Newson AJ; Best M; Badcock CA; Butow PN; Kirk J; Dunlop K; Fenton G; Cust AE
    Eur J Hum Genet; 2018 Aug; 26(8):1094-1100. PubMed ID: 29706632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary melanoma and predictive genetic testing: why not?
    Riedijk SR; de Snoo FA; van Dijk S; Bergman W; van Haeringen A; Silberg S; van Elderen TM; Tibben A
    Psychooncology; 2005 Sep; 14(9):738-45. PubMed ID: 15744786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.
    Wong XY; Chong KJ; van Til JA; Wee HL
    BMC Cancer; 2017 Nov; 17(1):776. PubMed ID: 29162038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sun protection practices among offspring of women with personal or family history of skin cancer.
    Geller AC; Brooks DR; Colditz GA; Koh HK; Frazier AL
    Pediatrics; 2006 Apr; 117(4):e688-94. PubMed ID: 16585282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin cancer: knowledge, behaviors, and attitudes of college students.
    Spradlin K; Bass M; Hyman W; Keathley R
    South Med J; 2010 Oct; 103(10):999-1003. PubMed ID: 20818308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communication by mothers with breast cancer or melanoma with their children.
    Gaber R; Desai S; Smith M; Eilers S; Blatt H; Guevara Y; Robinson JK
    Int J Environ Res Public Health; 2013 Aug; 10(8):3483-501. PubMed ID: 23965923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When we should worry more: using cognitive bias modification to drive adaptive health behaviour.
    Notebaert L; Chrystal J; Clarke PJ; Holmes EA; MacLeod C
    PLoS One; 2014; 9(1):e85092. PubMed ID: 24416344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High- and average-risk individuals' beliefs about, and perceptions of, malignant melanoma: an Australian perspective.
    Kasparian NA; Butow PN; Meiser B; Mann GJ
    Psychooncology; 2008 Mar; 17(3):270-9. PubMed ID: 17600854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.
    Aspinwall LG; Taber JM; Leaf SL; Kohlmann W; Leachman SA
    Psychooncology; 2013 Feb; 22(2):276-89. PubMed ID: 23382133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.